<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03168802</url>
  </required_header>
  <id_info>
    <org_study_id>N201609021</org_study_id>
    <nct_id>NCT03168802</nct_id>
  </id_info>
  <brief_title>MRgFUS and RFA for Treatment of Facet-joint Osteoarthritis Low Back Pain</brief_title>
  <official_title>Comparative Study of Magnetic Resonance-guided Focused Ultrasound and Radiofrequency Ablation for Treatment of Facet-joint Osteoarthritis Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Medical University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, two-arm, phase II study.&#xD;
&#xD;
      The purpose of this study is:&#xD;
&#xD;
        -  To evaluate and compare the efficacy and safety of magnetic resonance-guided focused&#xD;
           ultrasound (MRgFUS) and radiofrequency ablation (RFA) for treatment of facet-joint&#xD;
           osteoarthritis low back pain.&#xD;
&#xD;
        -  Determining the effect of the MRgFUS System and RFA for improving functional&#xD;
           disabilities and in reducing pain resulting from facet-joint osteoarthritis low back&#xD;
           pain. Efficacy will be determined by the level of pain relief (as measured by the&#xD;
           Numerical Rating Scale, NRS), decrease in analgesics/opiate, improved quality of life&#xD;
           (as measured by the Oswestry Disability Questionnaire, ODQ, and core outcome measures&#xD;
           index questionnaire, COMI), pain interference with function (as measured by the Brief&#xD;
           Pain Inventory-Interference scale, BPI-QoL), general health status (as measured by the&#xD;
           EQ5D), physical exam, X-ray and MRI studies from baseline up to 12-Months post- MRgFUS&#xD;
           and radiofrequency treatment.&#xD;
&#xD;
        -  Evaluate incidence and severity of adverse events associated with the MRgFUS system and&#xD;
           RFA used for the treatment of pain resulting from facet-joint osteoarthritis low back&#xD;
           pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 24, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>50 patients in each arm.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score change: Numerical Rating Scale (NRS)</measure>
    <time_frame>24-week post-treatment</time_frame>
    <description>Efficacy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score change: Numerical Rating Scale (NRS)</measure>
    <time_frame>1-, 4-, 8-, 12-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional scales change: Brief Pain Inventory-Quality of Life (BPI-QoL)</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional scales change: Oswestry Disability Questionnaire (ODQ)</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional scales change: Core Outcome Measurement Index (COMI)</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional scales change: EQ5D Quality of Life questionnaires</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of analgesic consumption</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Safety</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Physical exams for back range of motion</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </other_outcome>
  <other_outcome>
    <measure>X-ray for spine facet change</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <condition>Facet Joint Syndrome</condition>
  <arm_group>
    <arm_group_label>MRgFUS facet treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRgFUS ablation for facet joint pain once at Lumbar spine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiofrequency ablation facet treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radiofrequency ablation for facet joint pain once at Lumbar spine</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRgFUS ablation</intervention_name>
    <description>Focus ultrasound ablation therapy under MRI navigation for facet joint syndrome.</description>
    <arm_group_label>MRgFUS facet treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency ablation</intervention_name>
    <description>Radiofrequency ablation therapy under C-arm navigation for facet joint syndrome.</description>
    <arm_group_label>Radiofrequency ablation facet treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Men and women age 20 to 79 years old&#xD;
&#xD;
          2. Suffering from lumbar vertebral facet joint syndrome.&#xD;
&#xD;
          3. Lower back pain at least six months (NRSâ‰¥4).&#xD;
&#xD;
          4. Conventional treatment of pain includes NSAIDs, opioids, muscle relaxants, oral&#xD;
             steroids, physical therapy or chiropractic therapy.&#xD;
&#xD;
          5. Imaging of the spine have facet osteoarthritis.&#xD;
&#xD;
          6. Referred pain is no more below the knee.&#xD;
&#xD;
          7. At least once when local anesthesia or diagnostic medial nerve branch injection, pain&#xD;
             reduction&gt; 75% (0.5ml of 2% lidocaine).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with evidence of lumbosacral radiculopathy on MRI, CT or physical exam&#xD;
             findings, including radicular leg pain.&#xD;
&#xD;
          2. Patients with motor deficit or any other indication for surgical intervention.&#xD;
&#xD;
          3. Patients with MRgFUS or RF treatment for LBP within the last 6 months.&#xD;
&#xD;
          4. Patients with previous low back surgery.&#xD;
&#xD;
          5. Patients who are pregnant.&#xD;
&#xD;
          6. Patients with existing malignancy.&#xD;
&#xD;
          7. Patients with allergies to relevant contrast, anesthetics, sedation drugs.&#xD;
&#xD;
          8. Patients with contraindications for MRI.&#xD;
&#xD;
          9. Patients with an acute medical condition (e.g., pneumonia, sepsis) that is expected to&#xD;
             hinder them from completing this study.&#xD;
&#xD;
         10. Patients with unstable cardiac status including:&#xD;
&#xD;
               -  Unstable angina pectoris on medication&#xD;
&#xD;
               -  Patients with documented myocardial infarction less than 40 days prior to&#xD;
                  protocol enrolment&#xD;
&#xD;
               -  Patients with Severe Congestive Heart Failure, NYHA class 4.&#xD;
&#xD;
               -  Patients on anti-arrhythmic drugs or with uncontrolled and/or untreated&#xD;
                  arrhythmia status&#xD;
&#xD;
               -  Patients with pacemaker&#xD;
&#xD;
         11. Patients with severe cerebrovascular disease (CVA within last 6 months)&#xD;
&#xD;
         12. Patients with severe hypertension (diastolic BP &gt; 100 on medication)&#xD;
&#xD;
         13. Patients with an active infection or severe hematological, neurological, or other&#xD;
             uncontrolled disease.&#xD;
&#xD;
         14. Patients unable to communicate with the investigator and staff.&#xD;
&#xD;
         15. Patients who are not able or willing to tolerate the required prolonged stationary&#xD;
             position during treatment (approximately 2 hrs.)&#xD;
&#xD;
         16. Coagulation disorders or other bleeding disorders, use of anticoagulants or&#xD;
             antiplatelet drugs within 5 days before treatment.&#xD;
&#xD;
         17. When local anesthesia or diagnostic medial nerve branch injection, the pain does not&#xD;
             reach 75% (0.5 mL of 2% lidocaine).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yen Yun, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Taipei Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meng-Huang Wu, MD</last_name>
    <phone>227372181</phone>
    <phone_ext>3740</phone_ext>
    <email>maxwutmu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taipei medical university hospital</name>
      <address>
        <city>Taipei</city>
        <state>Please Select</state>
        <zip>11031</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meng-Huang Wu, MD</last_name>
      <phone>227372181</phone>
      <phone_ext>3740</phone_ext>
      <email>maxwutmu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Weeks EM, Platt MW, Gedroyc W. MRI-guided focused ultrasound (MRgFUS) to treat facet joint osteoarthritis low back pain--case series of an innovative new technique. Eur Radiol. 2012 Dec;22(12):2822-35. doi: 10.1007/s00330-012-2628-6. Epub 2012 Aug 31.</citation>
    <PMID>22935902</PMID>
  </reference>
  <reference>
    <citation>Kaye EA, Monette S, Srimathveeravalli G, Maybody M, Solomon SB, Gulati A. MRI-guided focused ultrasound ablation of lumbar medial branch nerve: Feasibility and safety study in a swine model. Int J Hyperthermia. 2016 Nov;32(7):786-94. doi: 10.1080/02656736.2016.1197972. Epub 2016 Jul 21.</citation>
    <PMID>27443328</PMID>
  </reference>
  <reference>
    <citation>Krug R, Do L, Rieke V, Wilson MW, Saeed M. Evaluation of MRI protocols for the assessment of lumbar facet joints after MR-guided focused ultrasound treatment. J Ther Ultrasound. 2016 Apr 6;4:14. doi: 10.1186/s40349-016-0057-8. eCollection 2016.</citation>
    <PMID>27054038</PMID>
  </reference>
  <reference>
    <citation>Maas ET, Ostelo RW, Niemisto L, Jousimaa J, Hurri H, Malmivaara A, van Tulder MW. Radiofrequency denervation for chronic low back pain. Cochrane Database Syst Rev. 2015 Oct 23;(10):CD008572. doi: 10.1002/14651858.CD008572.pub2. Review.</citation>
    <PMID>26495910</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2017</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Medical University Hospital</investigator_affiliation>
    <investigator_full_name>Meng-Huang Wu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Focused ultrasound Ablation</keyword>
  <keyword>Radiofrequency Ablation</keyword>
  <keyword>Facet joint syndrome</keyword>
  <keyword>Chronic low back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

